Chimerism testing permits early prediction and documentation of successful engraftment, and also facilitates detection of impending graft rejection. In this study, we serially monitored chimerism status by short tandem repeat-based PCR in nucleated cells (NC), T cells and natural killer (NK) cells after myeloablative allogeneic stem cell transplantation (SCT). Four patients with myeloid malignancies showed discrepant chimerism results among those three fractions. Three patients had mixed chimerism (MC) of donor/host T cells at a time point around the onset of chronic graft-versus-host disease (GVHD). In two patients with disease relapse, MC of NK cells preceded a morphological relapse or NK cells showed a higher percentage of patient cells compared to NC. Therefore, our study shows that chimerism analysis in lineage-specific cells might be useful in predicting clinical outcome after allogeneic SCT in certain patients. NC were isolated on density gradient centrifugation using Ficoll-Paque (d=1.077 g/mL, Pharmacia, Sweden). Genomic DNA was extracted from NC, CD3+ and CD56+ cells using QIAamp Blood Kit (Qiagen, Chatsworth, CA, USA).
CASE REPORTS

Chimerism analysis
Chimerism studies were performed using the AmpFlSTR Identifiler PCR Amplification Kit (Applied Biosystems, Foster City, CA, USA). PCR products were then analyzed using (Fig. 1C, arrow) . On day 190, blasts appeared in BM (54.5% of all NC), whereas PB blasts were not observed.
He died of pneumonia on day 237.
Case 4
A 47-yr-old male was diagnosed as MDS, refractory 
DISCUSSION
Chimerism analysis is now routinely performed and considered as an indicator for the recurrence of malignant or nonmalignant diseases [6] . Several studies have been performed during the last 20 yrs, and the consensus is that mixed chimerism (MC) is more associated with graft rejection than CC [7, 8] . study, we could confirm the usefulness as well as discrepancy of lineage-specific chimerism in at least four cases of myeloid malignancies.
In one AML case, 54.5% of blasts appeared in BM, whereas PB showed no blasts. In this patient, NK cell chimerism preceded a morphological relapse. Zeiser et al. [9] reported that conventional chimerism analysis had lower sensitivity of less than 3% compared to less than 0.1% of lineage-specific chimerism analysis. They also found that Data from Michallet et al. [12] showed a significant correlation between chimerism status and overall survival as well as the incidences of acute and chronic GVHD. Mattsson et al. [13] reported that about 82% of their patients had MC for donor/host T cells at the onset of acute GVHD.
Acute GVHD was not observed in our study and three 
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